In periodontitis, targeting the pathways that regulate efferocytosis—such as the MER receptor tyrosine kinase (MerTK) and Gas6 signaling—could be a therapeutic strategy to resolve chronic inflammation, limit tissue destruction, and promote periodontal regeneration [155]. The gene discussed is MERTK; the disease is periodontitis.